Combination of TACE and Sorafenib Improves Outcomes in BCLC Stages B/C of Hepatocellular Carcinoma: A Single Centre Experience

Combination of TACE and Sorafenib Improves Outcomes in BCLC Stages B/C of Hepatocellular Carcinoma: A Single Centre Experience

Background & Aim. Transarterial chemoembolization (TACE) or sorafenib is recommended for hepatocellular carcinoma BCLC stages B and C respectively. We studied the role of combination of TACE and sorafenib in BCLC stages B/C.Material and methods. We undertook an observational study on a cohor...

Full description

Bibliographic Details
Main Authors:	Joy Varghese, Chandan Kumar Kedarisetty, Jayanthi Venkataraman, Vijaya Srinivasan, Thiruchunapalli Deepashree, Mangerira Chinnappa Uthappa, Kaliamurthy Ilankumaran, Sanjay Govil, Mettu Srinivas Reddy, Mohamed Rela
Format:	Article
Language:	English
Published:	Elsevier 2017-03-01
Series:	Annals of Hepatology
Subjects:	Hepatoma Palliation Chronic liver disease Fibrosis Liver transplant
Online Access:	http://www.sciencedirect.com/science/article/pii/S1665268119303886

Similar Items

Management of Hepatitis B Virus Infection in Liver Transplant Recipients
by: Joy Varghese, et al.
Published: (2013-12-01)

The incorporation of formate-C¹⁴ into the nucleic acids of rats with regenerating liver and Novikoff hepatoma
by: Nixon, John Charles
Published: (2012)

Explant liver evaluation decodes the mystery of cryptogenic cirrhosis!
by: Mayank Jain, et al.
Published: (2020-02-01)

Diffuse Recurrence of Hepatocellular Carcinoma After Liver Resection: Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Monotherapy
by: Wang Yao, et al.
Published: (2020-12-01)

Seroprevalence of cytomegalovirus in donors & opportunistic viral infections in liver transplant recipients
by: Joy Varghese, et al.
Published: (2017-01-01)

Hepatitis B vaccination coverage among healthcare workers at national hospital in Tanzania: how much, who and why?
by: Dotto Aaron, et al.
Published: (2017-12-01)

A case-control study on the association of hepatitis B virus infection and hepatocellular carcinoma in Northeast Brazil
by: Helma Cotrim, et al.

Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm
by: Mandy Richani, et al.
Published: (2016-01-01)

Effects of In-Hospital Physical Therapy on Activities of Daily Living in Patients with Hepatocellular Carcinoma
by: Hayato Narao, et al.
Published: (2020-12-01)

Anaesthetic considerations for liver transplantation in propionic acidemia
by: Akila Rajakumar, et al.
Published: (2016-01-01)

Diabetes mellitus as a risk factor for hepatocellular carcinoma: A single-centre experience from South India
by: Mayank Jain, et al.
Published: (2019-01-01)

A case-control study on the association of hepatitis B virus infection and hepatocellular carcinoma in Northeast Brazil Estudo caso-controle da associação entre a infecção por vírus B da hepatite e carcinoma hepatocelular em uma área no nordeste brasileiro
by: Helma Cotrim, et al.
Published: (1992-10-01)

Incidence and risk factors for mortality in patients with cirrhosis awaiting liver transplantation
by: Mayank Jain, et al.
Published: (2019-01-01)

Preoperative risk stratification for early recurrence of HBV-related hepatocellular carcinoma after deceased donor liver transplantation: a five-eight model development and validation
by: Abdulahad Abdulrab Mohammed Al-Ameri, et al.
Published: (2019-11-01)

Investigation of glucocorticoid and dissociated glucocorticoid activity in hepatoma cell lines with specific reference to regulation of the corticosteroid binding globulin (CBG) proximal promoter'
by: Allie-Reid, Fatima
Published: (2012)

Lack of adaptation in lipogenesis by hepatoma 9121
by: J.C. Elwood, et al.
Published: (1968-05-01)

Laparoscopic Liver Resection Should Be a Standard Procedure for Hepatocellular Carcinoma with Low or Intermediate Difficulty
by: Ruoh-Yun Gau, et al.
Published: (2021-04-01)

Effect of TACE on liver function indexes in patients with primary liver cancer
by: Mei-Xue Ma, et al.
Published: (2017-06-01)

A case-control study on the association of hepatitis B virus infection and hepatocellular carcinoma in Northeast Brazil
by: Cotrim Helma, et al.
Published: (1992-01-01)

Comparison of Survival Rates Based on Recommended Treatment Algorithms of BCLC or HKLC Staging Systems for Hepatocellar Carcinoma Patients
by: DENG Guoyu, et al.
Published: (2019-04-01)

Stapleless laparoscopic left lateral sectionectomy for hepatocellular carcinoma: reappraisal of the Louisville statement by a young liver surgeon
by: Chao-Wei Lee, et al.
Published: (2018-11-01)

Transcatheter arterial chemoembolisation (TACE) plus S-1 for the treatment of BCLC stage B hepatocellular carcinoma refractory to TACE
by: Wu-Kui Huang, et al.
Published: (2017-01-01)

Prognostic ability of BCLC-B Subclassification in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
by: Marco Biolato, et al.
Published: (2018-01-01)

Enhanced anti-hepatoma effect of a novel curcumin analog C086 via solid dispersion technology
by: Yanping Deng, et al.
Published: (2020-01-01)

Caracterización clinicoepidemiológica y ecográfica de pacientes con masa hepática sólida Clinical epidemiological and ultrasonic characterization of patients with solid liver mass
by: Idania Santiesteban Garrido, et al.
Published: (2012-07-01)

Patient blood management in a patient with multiple red cell antibodies (anti-C, anti-e, and anti-K) undergoing liver transplant in South India: A team approach
by: Deepti Sachan, et al.
Published: (2020-01-01)

Transcriptional profiling in rats and an ex vivo analysis implicate novel beneficial function of egg shell membrane in liver fibrosis
by: Huijuan Jia, et al.
Published: (2013-10-01)

Anaesthesia and intensive care for simultaneous liver-kidney transplantation: A single-centre experience with 12 recipients
by: Akila Rajakumar, et al.
Published: (2016-01-01)

Activation of miR-101-3p/EZH2 pathway enhances sorafenib sensitivity of HepG2 cells
by: ZHANG Yueting, et al.
Published: (2020-11-01)

Malignant epithelioid hemangioendothelioma of the liver successfully treated with Sorafenib
by: Bruno Sangro, et al.
Published: (2012-06-01)

Cirrhotic cardiomyopathy- Survival at 3 months after liver transplantation
by: Ravikumar Bokarvadia, et al.
Published: (2019-01-01)

A rare adverse reaction of sorafenib
by: Wenwu Wang
Published: (2012-08-01)

Periprocedural Coagulation Status in Percutaneous Interventions
by: Soumil Singhal, et al.
Published: (2019-12-01)

Role of a Checklist to Improve Patient Safety in Interventional Radiology
by: Soumil Singhal, et al.
Published: (2019-07-01)

“Double Trouble”: Preoperative Embolization in a Case of Double Rupture of Hepatic Hemangioma during Pregnancy
by: Soumil Singhal, et al.
Published: (2019-06-01)

PROTEN TYROSINE PHOSPHATASE ACTIVITY IN RAT ASCITES HEPATOMA CELLS
by: M.Saadat, et al.
Published: (1998-10-01)

PROTEN TYROSINE PHOSPHATASE ACTIVITY IN RAT ASCITES HEPATOMA CELLS
by: M.Saadat, et al.
Published: (1998-12-01)

The effect of TACE combined with tumor interstitial therapy on immune globulin, complement and T lymphocyte subsets in patients with liver cancer
by: Bu-Tian Li, et al.
Published: (2016-07-01)

A prospective clinical trial on sorafenib treatment of hepatocellular carcinoma before liver transplantation
by: Malin Sternby Eilard, et al.
Published: (2019-06-01)

Combining Sorafenib and Immunosuppression in Liver Transplant Recipients with Hepatocellular Carcinoma
by: Koen G. A. M. Hussaarts, et al.
Published: (2021-01-01)

Cannot write session to /tmp/vufind_sessions/sess_qh8n7rlgj3qnd9lgkf4slmlpkk